Vraylar
Vraylar (cariprazine) is an atypical antipsychotic medication. It is believed to work through a combination of partial agonist activity at central dopamine D2 and serotonin 5-HT1A receptors, and antagonist activity at serotonin 5-HT2A receptors.
Dosage by Body Weight
Take orally once daily, with or without food. The recommended dose range is 1.5 mg to 6 mg once daily, depending on the indication. Dosages are adjusted gradually under medical supervision.
- Body Weight
- Below 5 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and effectiveness of Vraylar have not been established in pediatric patients.
- Body Weight
- 5-7 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and effectiveness of Vraylar have not been established in pediatric patients.
- Body Weight
- 8-10 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and effectiveness of Vraylar have not been established in pediatric patients.
- Body Weight
- 11-15 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and effectiveness of Vraylar have not been established in pediatric patients.
- Body Weight
- 16-20 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and effectiveness of Vraylar have not been established in pediatric patients.
| Body Weight | Dose | Frequency | Tracking Notes |
|---|---|---|---|
| Below 5 kg | Not recommended | N/A | Safety and effectiveness of Vraylar have not been established in pediatric patients. |
| 5-7 kg | Not recommended | N/A | Safety and effectiveness of Vraylar have not been established in pediatric patients. |
| 8-10 kg | Not recommended | N/A | Safety and effectiveness of Vraylar have not been established in pediatric patients. |
| 11-15 kg | Not recommended | N/A | Safety and effectiveness of Vraylar have not been established in pediatric patients. |
| 16-20 kg | Not recommended | N/A | Safety and effectiveness of Vraylar have not been established in pediatric patients. |
Formulation
Purpose
Vraylar is indicated for the treatment of schizophrenia in adults, acute manic or mixed episodes associated with bipolar I disorder, depressive episodes associated with bipolar I disorder (bipolar depression), and as an adjunctive treatment for major depressive disorder (MDD) in adults.
Generic Name
CariprazineScheduled Drug
No. This medicine is generally not treated as a scheduled/prescription-only drug in common consumer references, but local rules may vary.